Mirdametinib | Interleukin Related interleukin-related.com

Product Name :
Mirdametinib

Search keywords :
Mirdametinib

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase 2

Target Vo Short Name :
MEK2

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Neurofibroma, Plexiform

In Active Indication_Name:
Melanoma

Termination Status :

China Termination Status :

Highest Status:
NDA/BLA

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Stathmin 1 Rabbit mAb Data Sheet
Adipose Triglyceride Lipase Rabbit mAb Purity & Documentation
Toll-Like Receptor 3 Antibody (YA659): Toll-Like Receptor 3 Antibody (YA659) is a non-conjugated and Mouse origined monoclonal antibody about 104 kDa, targeting to Toll-Like Receptor 3 (2F10). It can be used for WB assays with tag free, in the background of Transfected.

Author: Interleukin Related

Related Posts